Ballicules.com
Spotty availability

Sodium polystyrene sulfonate

KAYEXALATE

What it isSodium polystyrene sulfonate, a cation exchange resin; hyperkalemia.

Why this oneUnlike newer potassium binders, its effect is poorly predictable and supported by weak evidence.

What limits itIt acts too slowly for emergencies, and sorbitol co-formulation has caused fatal colonic necrosis.

FDA label

FDA dosingPopulationStartTargetMax
Hyperkalemia (oral)Adults15 g (60 mL) QD15 g (60 mL) 1–4×/day60 g/day
Hyperkalemia (rectal enema)Adults30–50 g q6h30–50 g q6h
HyperkalemiaChildren/infantsDose based on 1 mEq potassium per gram of resin

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Animal reproduction studies not conducted; use only if clearly needed

Lactation Undefined

NO BOXED WARNINGS

Principal riskColonic necrosis with sorbitol; slow and poorly effective

Cost, est. cash$5–$500/month

Generic entry1982

Classes and tags

Clinical profile

Therapeutic safety burden0 / 4
Overdose danger0 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk0 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityLocal irritation, sensitization or administration-site injury; negligible systemic toxicity at usual use.

Mechanism of action: Sodium polystyrene sulfonate ballicule

Sodium polystyrene sulfonate ballicule: receptor binding, kinetics and half-life diagram

Open Sodium polystyrene sulfonate in the interactive console ↗

Memory aids: mascots and interaction avatars

Sodium polystyrene sulfonate KAYEXALATE mascot mnemonic cartoon
“Styro Polly, K+ extractor”
swaps Na+ for K+

Open Sodium polystyrene sulfonate in the interactive console ↗